KCNJ2 and type 1 diabetes mellitus: While control groups exhibited persistent T1D hyperglycemia, Kir2.1 expression in GABAArc neurons effectively reduced T1D to a normal level and this effect remained during the whole 8-week monitoring period (Fig. 4b).